Cellectar Biosciences, Inc. (CLRB) stock
CLRBNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.92−0.09 (-8.88%)
Close on Nov 17, 2026Market cap $8.70MP/E –Yield –
Cellectar Biosciences total assets
Total assets on the balance sheet at the end of each period.
Cellectar Biosciences's total assets was $36.64M at Jun 30, 2026. For fiscal 2025 it was $14.98M, down 41.2% from the year before. Over ten years it grew 7.0% a year on average. The highest annual figure on record is $58.66M in fiscal 2020.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $14.98M | -41.2% |
| FY2024 | Dec 31, 2024 | $25.47M | +111.0% |
| FY2023 | Dec 31, 2023 | $12.08M | -44.1% |
| FY2022 | Dec 31, 2022 | $21.59M | -42.0% |
| FY2021 | Dec 31, 2021 | $37.20M | -36.6% |
| FY2020 | Dec 31, 2020 | $58.66M | +378.8% |
| FY2019 | Dec 31, 2019 | $12.25M | -18.6% |
| FY2018 | Dec 31, 2018 | $15.05M | +17.0% |
| FY2017 | Dec 31, 2017 | $12.87M | -16.0% |
| FY2016 | Dec 31, 2016 | $15.32M | +101.7% |
| FY2015 | Dec 31, 2015 | $7.60M | -43.4% |
| FY2014 | Dec 31, 2014 | $13.42M | +96.9% |
| FY2013 | Dec 31, 2013 | $6.82M | -40.6% |
| FY2012 | Dec 31, 2012 | $11.48M | +8.7% |
| FY2011 | Dec 31, 2011 | $10.56M | +120.0% |
| FY2010 | Dec 31, 2010 | $4.80M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $36.64M | +167.5% |
| Q1 FY2026 | Mar 31, 2026 | $11.12M | -30.7% |
| Q4 FY2025 | Dec 31, 2025 | $14.98M | -41.2% |
| Q3 FY2025 | Sep 30, 2025 | $14.63M | -60.8% |
| Q2 FY2025 | Jun 30, 2025 | $13.70M | -53.4% |
| Q1 FY2025 | Mar 31, 2025 | $16.04M | -62.6% |
| Q4 FY2024 | Dec 31, 2024 | $25.47M | +111.0% |
| Q3 FY2024 | Sep 30, 2024 | $37.29M | +73.0% |
| Q2 FY2024 | Jun 30, 2024 | $29.38M | +351.4% |
| Q1 FY2024 | Mar 31, 2024 | $42.91M | +189.2% |
| Q4 FY2023 | Dec 31, 2023 | $12.08M | -44.1% |
| Q3 FY2023 | Sep 30, 2023 | $21.55M | +11.5% |
| Q2 FY2023 | Jun 30, 2023 | $6.51M | -74.9% |
| Q1 FY2023 | Mar 31, 2023 | $14.84M | -53.6% |
| Q4 FY2022 | Dec 31, 2022 | $21.59M | -42.0% |
| Q3 FY2022 | Sep 30, 2022 | $19.32M | -53.9% |
| Q2 FY2022 | Jun 30, 2022 | $25.89M | -45.8% |
| Q1 FY2022 | Mar 31, 2022 | $31.99M | -41.9% |
| Q4 FY2021 | Dec 31, 2021 | $37.20M | -36.6% |
| Q3 FY2021 | Sep 30, 2021 | $41.95M | +102.7% |
| Q2 FY2021 | Jun 30, 2021 | $47.74M | +100.1% |
| Q1 FY2021 | Mar 31, 2021 | $55.06M | +533.7% |
| Q4 FY2020 | Dec 31, 2020 | $58.66M | +378.8% |
| Q3 FY2020 | Sep 30, 2020 | $20.70M | +32.2% |
| Q2 FY2020 | Jun 30, 2020 | $23.85M | +24.6% |
| Q1 FY2020 | Mar 31, 2020 | $8.69M | -30.8% |
| Q4 FY2019 | Dec 31, 2019 | $12.25M | -18.6% |
| Q3 FY2019 | Sep 30, 2019 | $15.66M | -19.9% |
| Q2 FY2019 | Jun 30, 2019 | $19.14M | +173.5% |
| Q1 FY2019 | Mar 31, 2019 | $12.55M | +31.2% |
| Q4 FY2018 | Dec 31, 2018 | $15.05M | +17.0% |
| Q3 FY2018 | Sep 30, 2018 | $19.54M | +98.0% |
| Q2 FY2018 | Jun 30, 2018 | $7.00M | -44.5% |
| Q1 FY2018 | Mar 31, 2018 | $9.56M | -37.5% |
| Q4 FY2017 | Dec 31, 2017 | $12.87M | -16.0% |
| Q3 FY2017 | Sep 30, 2017 | $9.87M | +6.2% |
| Q2 FY2017 | Jun 30, 2017 | $12.60M | – |
| Q1 FY2017 | Mar 31, 2017 | $15.30M | – |
| Q4 FY2016 | Dec 31, 2016 | $15.32M | – |
| Q3 FY2016 | Sep 30, 2016 | $9.30M | – |
See a number that looks wrong?